Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Grant Opportunity Analysis
The National Institutes of Health (NIH) has announced a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research" (R01 Clinical Trial Required), aimed at supporting innovative research on alcohol use disorder (AUD) treatment and recovery. This initiative seeks applications that focus on various aspects of AUD, including medication development, behavioral therapies, mechanisms of behavioral change, and translational research, with an emphasis on addressing health disparities among underserved populations. The maximum funding amount available is $500,000 per year, with projects potentially lasting up to five years, and applications must be submitted electronically via Grants.gov by the deadline of September 7, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.